Son, J., Du, W., Esposito, M., Shariati, K., Ding, H., Kang, Y., & Accili, D. (2023). Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure. Nature Communications, 14(1). https://doi.org/10.1038/s41467-023-36315-4

Hsu, C.-C., Fidler, T. P., Kanter, J. E., Kothari, V., Kramer, F., Tang, J., Tall, A. R., & Bornfeldt, K. E. (2023). Hematopoietic NLRP3 and AIM2 Inflammasomes Promote Diabetes-Accelerated Atherosclerosis, but Increased Necrosis Is Independent of Pyroptosis. Diabetes, 72(7), 999–1011. https://doi.org/10.2337/db22-0962

Aiello, J. J., Bogart, M. C., Chan, W.-T., Holoman, N. C., Trobenter, T. D., Relf, C. E., Kleinman, D. M., De Vivo, D. C., & Samuels, I. S. (2023). Systemic Reduction of Glut1 Normalizes Retinal Dysfunction, Inflammation, and Oxidative Stress in the Retina of Spontaneous Type 2 Diabetic Mice. The American Journal of Pathology, 193(7), 927–938. https://doi.org/10.1016/j.ajpath.2023.04.003

Manigrasso, M. B., Rabbani, P., Egaña-Gorroño, L., Quadri, N., Frye, L., Zhou, B., Reverdatto, S., Ramirez, L. S., Dansereau, S., Pan, J., Li, H., D’Agati, V. D., Ramasamy, R., DeVita, R. J., Shekhtman, A., & Schmidt, A. M. (2021). Small-molecule antagonism of the interaction of the RAGE cytoplasmic domain with DIAPH1 reduces diabetic complications in mice. Science Translational Medicine, 13(621). https://doi.org/10.1126/scitranslmed.abf7084